摘要
目的:观察中药复方清瘟败毒饮对脓毒症(气营两燔证)的临床疗效以及对部分血清免疫学指标的影响。方法:将49例脓毒症患者随机分为西医常规治疗加清瘟败毒饮组(治疗组)25例、西医常规治疗组(对照组)24例,观察疗程7d,分别比较治疗前后中医症状积分、APACHEⅡ评分以及治疗前后外周静脉血IgG、IgA、IgM、C3、CRP、TNF-α水平(值)的变化。结果:两组总疗效比较无差异,但治疗组临床控制率优于对照组(P<0.05);两组患者与本组治疗前比较,中医症状积分和APACHEⅡ评分分值均明显下降(P<0.05,P<0.01),但同期比较治疗组优于对照组(P<0.05);两组患者与本组治疗前比较,IgG、IgA、IgM、C3、CRP、TNF-α水平(值)均降低(P<0.05,P<0.01),但治疗组同期优于对照组(P<0.05)。结论:清瘟败毒饮能提高脓毒症的临床疗效,有抑制脓毒症患者过度免疫应答、减少过度免疫应答对机体自身的损害方面的作用。
Objective: To observe the clinical effects of Qingwenbaiduyin in the treatment of sepsis(vigorous heat at qi-blood phase),and its effects on some immunological parameters in serum.Methods: 49 cases of sepsis were randomly assigned to treatment with conventional Western medicine plus Qingwenbaiduyin group(treatment group) in 25 cases,conventional Western medicine treatment group(control group) in 24 cases.They were observed 7 treatment days.And contrast the before and after treatment Chinese medicine symptom score,PACHE Ⅱ score and peripheral blood before and after treatment IgG,IgA,IgM,C3,CRP,TNF-α level(value) changes,respectively.Results: The total effect of the two groups showed no difference,but the treatment group clinical control is superior to the control group(P〈0.05).After treatment,the two groups Chinese medicine symptom score and APACHE Ⅱ score were significantly decreased(P〈0.05),but the treatment group is superior to the control group(P〈0.05);two groups before and after treatment of patients with IgG,IgA,IgM,C3,CRP,TNF-α levels(values) were lower(P〈0.05,P〈0.01),but treatment group is superior to the control group(P〈0.05).Conclusion: Qingwenbaiduyin can improve the clinical efficacy of sepsis,inhibit excessive immuneresponse in patients with sepsis and reduce the damage due to excessive immune response.
出处
《中华中医药杂志》
CAS
CSCD
北大核心
2012年第3期758-760,共3页
China Journal of Traditional Chinese Medicine and Pharmacy
基金
四川省教育厅科研基金项目(No.09ZC043)~~
关键词
脓毒症
免疫调节
清瘟败毒饮
中西结合治疗
Sepsis; Immunoregulation; Qingwenbaiduyin; Chinese and western integrated method